224 related articles for article (PubMed ID: 33032998)
1. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden.
Molander V; Bower H; Frisell T; Askling J
Ann Rheum Dis; 2021 Feb; 80(2):169-175. PubMed ID: 33032998
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.
Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J;
Ann Rheum Dis; 2023 Feb; 82(2):189-197. PubMed ID: 36150749
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis.
Pedersen AB; Vandenbroucke J; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2017 Dec; 15(12):2325-2332. PubMed ID: 28913891
[TBL] [Abstract][Full Text] [Related]
5. Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
Molander V; Bower H; Askling J
Scand J Rheumatol; 2023 Mar; 52(2):111-117. PubMed ID: 35023437
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism in patients with rheumatoid arthritis.
Kim SC; Schneeweiss S; Liu J; Solomon DH
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917
[TBL] [Abstract][Full Text] [Related]
7. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.
Li L; Lu N; Avina-Galindo AM; Zheng Y; Lacaille D; Esdaile JM; Choi HK; Aviña-Zubieta JA
Rheumatology (Oxford); 2021 Jan; 60(1):188-195. PubMed ID: 32617563
[TBL] [Abstract][Full Text] [Related]
8. Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?
Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669456
[TBL] [Abstract][Full Text] [Related]
9. Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: A register-based cohort study from Denmark.
Cordtz R; Odgaard A; Kristensen LE; Overgaard S; Dreyer L
Semin Arthritis Rheum; 2020 Feb; 50(1):30-35. PubMed ID: 31272806
[TBL] [Abstract][Full Text] [Related]
10. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
[TBL] [Abstract][Full Text] [Related]
11. Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
Yoshimura M; Fujieda Y; Sugawara M; Kono M; Kato M; Yokota I; Amengual O; Ito YM; Atsumi T
Rheumatol Int; 2022 Nov; 42(11):1939-1946. PubMed ID: 35384451
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
Ozen G; Pedro S; Schumacher R; Simon T; Michaud K
RMD Open; 2021 Jun; 7(2):. PubMed ID: 34193517
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in rheumatoid arthritis.
Ketfi C; Boutigny A; Mohamedi N; Bouajil S; Magnan B; Amah G; Dillinger JG
Joint Bone Spine; 2021 May; 88(3):105122. PubMed ID: 33346109
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.
Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM
Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
Gamboa-Cárdenas RV; Ugarte-Gil MF; Loreto M; Sacnun MP; Saurit V; Cardiel MH; Soriano ER; Pisoni C; Galarza-Maldonado CM; Rios C; Radominski SC; Castelar-Pinheiro GDR; Bianchi WA; Appenzeller S; da Silveira IG; de Freitas Zerbini CA; Caballero-Uribe CV; Rojas-Villarraga A; Guibert-Toledano M; Ballesteros F; Montufar R; Vázquez-Mellado J; Esquivel-Valerio J; De La Torre IG; Barile-Fabris LA; Palezuelos FI; Andrade-Ortega L; Monge P; Teijeiro R; Achurra-Castillo ÁF; Esteva Spinetti MH; Alarcón GS; Pons-Estel BA
Clin Rheumatol; 2019 Oct; 38(10):2737-2746. PubMed ID: 31161486
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
Hirata S; Saito K; Kubo S; Fukuyo S; Mizuno Y; Iwata S; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
Arthritis Res Ther; 2013 Sep; 15(5):R135. PubMed ID: 24286472
[TBL] [Abstract][Full Text] [Related]
19. Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature.
Conforti A; Berardicurti O; Pavlych V; Di Cola I; Cipriani P; Ruscitti P
Medicine (Baltimore); 2021 Aug; 100(33):e26953. PubMed ID: 34414960
[TBL] [Abstract][Full Text] [Related]
20. Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.
Liang H; Danwada R; Guo D; Curtis JR; Kilpatrick RD; Hendrickson B; Islam SS
RMD Open; 2019; 5(2):e001013. PubMed ID: 31673413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
